摘要
胰腺癌治疗效果差，其重要原因就是早期诊断率低。血清肿瘤标志物以其独特的优势成为筛查胰腺癌患者最理想的检测方法。随着蛋白组学的发展，研究发现了很多新的血清肿瘤标志物，如载脂蛋白Apo A-Ⅱ、ApoC-Ⅰ、MBL2、MLCK2、REG4蛋白等。本文将就胰腺癌血清肿瘤标志物的研究进展作一综述。
Pancreatic cancer has a bad curative effect because of low rate of early diagnosis. Plasma cancer marker becomes the most ideal screening method for the special advantages. With the development of proteomics, many new plasma cancer markers, such as apolipoprotei A- Ⅱ, apolipoprotei C- Ⅰ, MBL2 、ML- CK2, REG4 and so on, have been detected. The article describes the research progress of plasma tumor marker.
出处
《国际外科学杂志》
2012年第2期114-117,共4页
International Journal of Surgery
关键词
蛋白组学
胰腺癌
血清肿瘤标志物
Proteomics
Pancreatic neoplasms
Plasma cancer marker
